Yea, I don't pretend to know the details of what the debt covenant etc. I just take what management reports claims are the new terms, that they're being met.
Would be a good idea to look at peer and competitors, but a situation like MRM need a very close look to really have a hope and a prayer that it's going to turn out well. So peer review, to my mind anyway, might not do much beside indicating an earning/job turnaround.
I'm in to MRM for its assets. Conditions have definitely deteriorated since I got in, about, I think late 2015.
But look at this beautiful chart...
$1.5 billion investment in its assets. With the massive writedowns of hundreds of millions over the past three years, its PPE book value was still $875M. Minus the $75 for the sales, but then that also remove the debt... but say it's $600M after all the write downs.
At 16cents a share, that's some $60M for the entire company.... or 10 cent on a dollar.
Maybe cigar butt smoking will really hurt me, but hmm.... so far, it won't be cancerous, yet
MRM Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held